排序方式: 共有33条查询结果,搜索用时 171 毫秒
1.
2.
3.
4.
MÖ Hergüner SK GüneLer DU AltintaL ZN Alparslan M Yilmaz P Aksungur 《Acta paediatrica (Oslo, Norway : 1992)》1997,86(5):454-455
This study was conducted on 1359 healthy, non-smoking Turkish children (727M, 632F) with a mean age of 11.7 ± 3.4 (6–17) years, in order to determine the normal values of peak expiratory flow (PEF) in Turkish children and to compare various peak-flow meters (PEFMs). PEF values increased with age and height in boys and girls. The relative increase in boys was significantly higher at puberty (p < 0.01). The values of Turkish children were found to be similar to those of Europeans. The results obtained from the three PEFMs were closely correlated. 相似文献
5.
Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs 总被引:3,自引:3,他引:3
Silber R; Degar B; Costin D; Newcomb EW; Mani M; Rosenberg CR; Morse L; Drygas JC; Canellakis ZN; Potmesil M 《Blood》1994,84(10):3440-3446
Chemosensitivity of B lymphocytes, obtained from 65 patients with B- cell chronic lymphocytic leukemia (B-CLL), Rai stages 0 through IV, was determined using the MTT assay. The results were expressed by the drug concentration required for 50% inhibition of cell viability (IC50). The cytotoxicity of chlorambucil (CLB) was compared with that of fludarabine and the DNA topoisomerase I inhibitors, camptothecin, 9- aminocamptothecin, 10,11-methylenedioxy-20(S)-camptothecin (10,11-MDC) and 9-amino-10,11-methylenedioxy-20(S)-campthothecin (9-A-10,11-MDC), and topotecan. Considerable heterogeneity in sensitivity to CLB was observed, with a median IC50 of 40.5 mumol/L in untreated patients. B- CLL cells from patients treated with CLB had a significantly higher median IC50 of 86.0 mumol/L (P < .01). Untreated as well as CLB-treated patients were divided into two subsets. For the purpose of this study, B-CLL lymphocytes with an IC50 CLB of less than 61.0 mumol/L were designated as "sensitive" and those with an IC50 CLB of > or = 61.0 mumol/L were designated as "resistant." After baseline assays, 15 untreated patients received CLB; after treatment, the IC50 increased in B-CLL lymphocytes from 13 of 15 patients. The response to CLB treatment, determined by its effect on the absolute lymphocyte count and by the Eastern Cooperative Oncology Group clinical criteria, was significantly better in patients whose lymphocytes had an IC50 CLB of less than 61.0 mumol/L before therapy (P < .01). B-CLL lymphocytes also had a variable degree of sensitivity in vitro to each of the other drugs. There was significant cross-resistance between CLB and fludarabine (P < 0.01). Whereas only 29% of CLB-resistant B-lymphocyte specimens obtained from individual patients were sensitive to fludarabine in vitro, 52% and 67% of CLB-resistant lymphocyte samples were sensitive to 10,11-MDC and 9-A-10,11-MDC, respectively. We have previously reported that p53 gene mutations were associated with aggressive B-CLL and a poor prognosis. B lymphocytes from seven patients with these mutations were resistant to CLB, and five of six were resistant to fludarabine. Lymphocytes from four of seven were resistant to 10,11-MDC, and three of four were resistant to 9-A-10,11- MDC. This study implies that the MTT assay may be useful in identifying subsets of CLL patients resistant to conventional chemotherapy. However, definitive conclusions can not be drawn in view of the small number of patients studied prospectively. In addition, these results suggest the potential of camptothecin-based therapy for patients unresponsive to standard treatment. 相似文献
6.
7.
Lems WF; Jahangier ZN; Raymakers JA; Jacobs JW; Bijlsma JW 《Rheumatology (Oxford, England)》1997,36(2):220-224
8.
Ana ZN Bergamo Paulo Nelson-Filho Fábio L Romano Raquel AB da Silva Maria CP Saraiva Lea AB da Silva 《Journal of orthodontics》2016,43(4):260-267
Objective: The aim of this study was to evaluate the alterations on plaque index (PI), gingival index (GI), gingival bleeding index (GBI), and gingival crevicular fluid (GCF) volume after use of three different brackets types for 60 days. Setting Participants: The sample comprised 20 patients of both sexes aged 11–15 years (mean age: 13.3 years), with permanent dentition, adequate oral hygiene, and mild tooth crowding, overjet, and overbite. Methods: A conventional metallic bracket Gemini?, and two different brands of self-ligating brackets — In-Ovation®R and SmartClip? — were bonded to the maxillary incisors and canines. PI, GI, GBI scores, and GCF volume were measured before and 30 and 60 days after bonding of the brackets. Data were analysed statistically using non-parametric tests coefficient at a 5% significance level. Results: There was no statistically significant correlation (P?>?0.05) between tooth crowding, overjet, and overbite and the PI, GI, GBI scores, and GCF volume before bonding, indicating no influence of malocclusion on the clinical parameters. Regardless of the bracket design, no statistically significant difference (P?>?0.05) was found for GI, GBI scores. PI and GCF volume showed a significant difference among the brackets in different periods. In pairwise comparisons a significant difference was observed when compared before with 60 days after bonding, for the teeth bonded with SmartClip? self-ligating bracket, (PI P?=?0.009; GCF volume P?=?0.001). Conclusion: There was an increase in PI score and GCF volume 60 days after bonding of SmartClip? self-ligating brackets, indicating the influence of bracket design on these clinical parameters. 相似文献
9.
10.
0 引言 凋亡或细胞程序性死亡是一种不同于细胞坏死的死亡方式 ,是在基因控制下的有序死亡 ,是一个主动性自杀过程 ,常伴有特征性形态学和生化变化 .临床上放射线治疗肿瘤主要应用射线诱导细胞凋亡这一机制 .1 88Re发射 2 110Ke V的 β射线 ,15 5 Ke Vγ射线 ,半衰期 17h,具有良好的核物理性质 .国外 1 88Re的研究主要在 1 88Re标记单克隆抗体对肿瘤的放射免疫治疗 ,并显示具有一定的疗效 ,而国内关于 1 88Re的研究较少 ,经文献检索未见有关于 1 88Re诱导细胞凋亡的报道 .本实验旨在研究 1 88Re-β射线诱导人肝癌细胞系 h HCC(human… 相似文献